Evorel Conti

Evorel Conti is a hormone replacement therapy patch used to relieve menopause symptoms and prevent bone loss in women who have stopped having periods.

Form
depotlaastari
Active Ingredient
Estradiol hemihydrate
Manufacturer
Theramex Ireland Limited

How to Use

Dosage

Use Evorel Conti continuously by applying a new patch to your skin twice a week.

Method

Apply the patch to clean, dry skin below your waist, not on your breasts. Change the patch location each time, and wait at least a week before using the same spot again.

Important

Use only one patch at a time.

Possible Side Effects

COMMON
  • Headache
  • Breast pain or tenderness
  • Menstrual problems (like pain or irregular bleeding)
  • Skin irritation where the patch is applied
  • Mood changes (feeling down, nervous, anxious)
  • Dizziness
  • Nausea or stomach upset (bloating, diarrhea, stomach pain)
  • Skin rash or itching
  • Back or joint pain
  • Swelling or weight gain
RARE
  • Migraine
  • Vomiting or gas
  • Muscle pain or weakness
  • Skin discoloration (dark spots, especially on the face or neck)
  • Changes in sex drive
  • Tingling sensation in the skin
  • Gallbladder problems or gallstones
  • Hair loss
  • Severe skin reactions (like painful red bumps or widespread rashes)
  • Dry eyes or changes in tear fluid

Important Warnings

  • Do not use if you have or suspect breast cancer or other cancer sensitive to estrogen.
  • Stop using the patch and contact your doctor immediately if you become pregnant.
  • Stop using the patch and contact your doctor immediately if you notice signs of a blood clot, like painful leg swelling, sudden chest pain, or trouble breathing.
  • Stop using the patch and contact your doctor immediately if your skin or eyes turn yellow (jaundice).
  • Stop using the patch and contact your doctor immediately if you have signs of a severe allergic reaction, such as swelling of your face, tongue, or throat, or difficulty breathing.

Use in Elderly Patients

Category D

Systemic use: Avoid use in older adults. In systemic use, consider potential adverse effects, such as risk of cardiovascular diseases and venous thromboembolism. Consider potential interactions. (updated 21.10.2024)